AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
Irish pharmaceutical company Elan Corp Plc has received approval from the US Food and Drug Administration (FDA) for new versions of its Skelaxin and Zanaflex drugs.
The FDA approved a supplemental new drug application (sNDA) for an 800mg strength Skelaxin (metaxalone) tablet and a new drug application (NDA) for a capsule form of Elan's Zanaflex (tizanidine hydrochloride) drug in 2mg, 4mg and 6mg doses. …